Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-31

Clinical Trial Update: Effect of Erythropoiesis-Stimulating Agent Therapy in Patients Receiving Palliative Care of Chronic Kidney Disease

View source ↗

Summary

This clinical trial update summarizes erythropoiesis-stimulating agent therapy in patients with anemia of chronic kidney disease in a palliative care setting. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoiesis-Stimulating Agent Therapy

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Anemia of Chronic Kidney Disease | Status: COMPLETED